News | May 21, 2015

Latest version supports planning for multiple patients simultaneously across multiple treatment techniques

Elekta, Monaco, v5.10, CE Mark

May 21, 2015 — Elekta has CE marked the latest version (v5.10) of its popular Monaco treatment planning system, enabling its sale to European clinics. The system supports major treatment techniques including advanced 3-D planning, intensity modulated radiation therapy (IMRT), volumetric arc therapy (VMAT) and stereotactic planning – all in a single system.

Monaco v5.10 provides significant planning and quality assurance (QA) enhancements, as well improved workflow efficiency. Advancements in 3-D planning as well as the addition of magnetic resonance imaging (MRI) and forward planning capabilities further reinforces Monaco as a robust and flexible treatment planning solution. Now, users can simplify their planning with advanced time-saving tools, speed up workflow and ultimately create better plans with fewer contours and therefore less variability.

Furthermore, utilizing the Monte Carlo algorithm, Monaco now enables users to recalculate third-party plans for quality assurance checks.

Key Monaco v5.10 benefits designed to improve planning time enable clinicians to:

  • Optimize plan creation with customizable templates that can be shared across institutions;
  • Plan multiple patients simultaneously;
  • Achieve better dose conformity with state-of-the art optimization tools;
  • Create multiple prescriptions within a single active plan; and
  • Quickly learn and use the system through its modern, intuitive interface.

 

For more information: www.elekta.com


Related Content

News | Radiation Therapy

April 18, 2024 — Accuray Incorporated announced that as part of its commitment to advancing patient care the company has ...

Time April 18, 2024
arrow
News | Artificial Intelligence

March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...

Time March 28, 2024
arrow
News | Prostate Cancer

March 27, 2024 — A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation ...

Time March 27, 2024
arrow
Videos | Radiation Oncology

In the conclusion of this 3-part video series on recent advancements in diagnostic radiology, current editorial advisory ...

Time March 19, 2024
arrow
News | Breast Imaging

March 18, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time March 18, 2024
arrow
Feature | Radiation Oncology | By Christine Book

Appreciating the considerable advances in the clinical application of artificial intelligence (AI) within healthcare ...

Time March 06, 2024
arrow
News | FDA

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
arrow
News | Breast Imaging

February 22, 2024 — The FAST-Forward randomized trial from the UK found that ultrahypofractionated whole breast ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 22, 2024 — The National Institutes of Health has launched a clinical trials network to evaluate emerging ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 14, 2024 — Accuray Incorporated announced that the team at Quebec’s Montérégie Integrated Cancer Center, part ...

Time February 14, 2024
arrow
Subscribe Now